"/> Novus Biologicals™ Peptide bloquant d’anticorps SL… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps SLC39A13

Réf. : BL-RE-045769Réf. fabricant : 18218577
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
91252
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76509. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 14 amino acid peptide near the amino terminus of human ZIP13.

Points forts

Source

Synthetic

(Accession #: NP_001121697) The SLC39A13 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-045769
Réf. fabricant18218577
Gene ID (Entrez)91252
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76509. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneFLJ25785, LIV-1 subfamily of ZIP zinc transporter 9, LZT-Hs9, solute carrier family 39 (metal ion transporter), member 13, solute carrier family 39 (zinc transporter), member 13, Solute carrier family 39 member 13, zinc transporter ZIP13, ZIP13, ZIP-13, Zrt- and Irt-like protein 13
Symbole de gène(s)SLC39A13
Type de produitSLC39A13
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne14 amino acid peptide near the amino terminus of human ZIP13
Une question, une configuration particulière ?
Contactez-nous pour un devis.